Type 1 diabetes trials in Sweden
19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Linkoping, Lund, Moelndal, Orebro, Stockholm
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Malmö, Orebro
- Age
- 1 year to 35 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Lund, Orebro, Ostersund, Stockholm, Uddevalla
- Age
- 1 year to 35 years
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - Phase 4Taking peopleAnti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
- Where
- Malmo
- Age
- Up to 17 years
- People
- 2,365 worldwide
- Run by
- Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Vänersborg
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseEnrolling by invitationInformation, Follow-up and Early Diagnosis of Children at Risk for Type 1 Diabetes
- Where
- Malmö
- Age
- 0 years to 18 years
- People
- 600
- Run by
- Lund University
See details and how to joinNCT06676566 - No phaseTaking peopleIntensive Dietary and Activity Counselling (IDAC)
- Where
- Malmö
- Age
- 3 months to 4 months
- People
- 1,244
- Run by
- Lund University
See details and how to joinNCT06670625 - No phaseTaking peopleDiabetes Intervention Involving Person-centred Nutritional Education
- Where
- Enköping
- Age
- 18 years and over
- People
- 54
- Run by
- Umeå University
See details and how to joinNCT07258758 - No phaseNot yet taking people in SwedenTherapeutic Outcomes of Using Complementary Hand-based Treatment in Diabetes
- Where
- Norrköping
- Age
- 18 years and over
- People
- 20
- Run by
- University Hospital, Linkoeping
See details and how to joinNCT07275086 - No phaseTaking peopleSingle Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
- Where
- Mölndal
- Age
- 18 years and over
- People
- 40
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06549023 - Phase 1/2Taking peopleA Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil
- Where
- Jonkoping, Linkoping
- Age
- 4 years to 9 years
- People
- 36
- Run by
- Johnny Ludvigsson
See details and how to joinNCT07199946 · EU 2024-515106-30-00 - Phase 4Taking peopleAnti-viral Action Against Type 1 Diabetes Autoimmunity
- Where
- Malmö
- Age
- 3 months to 4 months
- People
- 2,252 worldwide
- Run by
- Technical University of Munich
See details and how to joinNCT06452654 - No phaseTaking peopleThe Skin Barrier in Users of Diabetes Devices
- Where
- Linköping
- Age
- 2 years to 17 years
- People
- 150
- Run by
- Jannet Svensson
See details and how to joinNCT06856954 - No phaseTaking peopleThe MIND Study - Microangiopathy IN Diabetes
- Where
- Stockholm
- Age
- 18 years to 60 years
- People
- 400
- Run by
- HJN Sverige AB/Neko Health
See details and how to joinNCT06989190 - No phaseTaking peopleMortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes
- Where
- Stockholm
- Age
- 18 years to 110 years
- People
- 900,000
- Run by
- Karolinska Institutet
See details and how to joinNCT06563401 - Phase 2Taking peopleDesferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) - A randomised, double-blind, placebo-controlled, cross-over study
- Where
- Solna
- Age
- 18 years to 64 years
- People
- 30
- Run by
- Karolinska University Hospital
See details and how to joinNCT03085771 · EU 2024-519562-48-00 - Early phase 1Taking peopleFirst-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
- Where
- Uppsala
- Age
- 30 years to 45 years
- People
- 2
- Run by
- Per-Ola Carlsson
See details and how to joinNCT06239636 · EU 2023-507988-19-00 - No phaseTaking peopleTreating Diabetic Foot Ulcers, Comparing Two Topical Antimicrobial Agents, Dakin´s and Prontosan
- Where
- Uddevalla
- Age
- 18 years to 100 years
- People
- 202
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05132179 - No phaseTaking peopleOptimized Care of People With Diabetes and Foot Complication in Primary Care
- Where
- Gothenburg
- Age
- 18 years and over
- People
- 140
- Run by
- Sahlgrenska University Hospital
See details and how to joinNCT05692778